These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 14640888)

  • 1. Pathophysiological and clinical importance of insulin-like growth factor-I with respect to bone metabolism.
    Zofková I
    Physiol Res; 2003; 52(6):657-79. PubMed ID: 14640888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anabolic effects of GH/IGF system on bone.
    Kasukawa Y; Miyakoshi N; Mohan S
    Curr Pharm Des; 2004; 10(21):2577-92. PubMed ID: 15320746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone, insulin-like growth factors, and the senescent skeleton: Ponce de Leon's Fountain revisited?
    Rosen CJ
    J Cell Biochem; 1994 Nov; 56(3):348-56. PubMed ID: 7876328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone, insulin-like growth factors, and the skeleton.
    Giustina A; Mazziotti G; Canalis E
    Endocr Rev; 2008 Aug; 29(5):535-59. PubMed ID: 18436706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of metabolic acidosis on the growth hormone/IGF-I endocrine axis in skeletal growth centers.
    Green J; Maor G
    Kidney Int; 2000 Jun; 57(6):2258-67. PubMed ID: 10844596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skeletal effects of growth hormone and insulin-like growth factor-I therapy.
    Lindsey RC; Mohan S
    Mol Cell Endocrinol; 2016 Sep; 432():44-55. PubMed ID: 26408965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IGF-I and osteoporosis.
    Rosen CJ
    Clin Lab Med; 2000 Sep; 20(3):591-602. PubMed ID: 10986623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conditional deletion of insulin-like growth factor-I in collagen type 1alpha2-expressing cells results in postnatal lethality and a dramatic reduction in bone accretion.
    Govoni KE; Wergedal JE; Florin L; Angel P; Baylink DJ; Mohan S
    Endocrinology; 2007 Dec; 148(12):5706-15. PubMed ID: 17717052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A transgenic model to determine the physiological role of liver-derived insulin-like growth factor I.
    Sjögren K; Jansson JO; Isaksson OG; Ohlsson C
    Minerva Endocrinol; 2002 Dec; 27(4):299-311. PubMed ID: 12511852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the GH/IGF-1 axis contribute to skeletal sexual dimorphism? Evidence from mouse studies.
    Liu Z; Mohan S; Yakar S
    Growth Horm IGF Res; 2016 Apr; 27():7-17. PubMed ID: 26843472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spatial and temporal regulation of GH-IGF-related gene expression in growth plate cartilage.
    Parker EA; Hegde A; Buckley M; Barnes KM; Baron J; Nilsson O
    J Endocrinol; 2007 Jul; 194(1):31-40. PubMed ID: 17592018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexamethasone-induced abnormalities in growth and bone metabolism in piglets are partially attenuated by growth hormone with no synergistic effect of insulin-like growth factor-I.
    Ward WE; Donovan SM; Atkinson SA
    Pediatr Res; 1998 Aug; 44(2):215-21. PubMed ID: 9702917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal bone growth in vitro: effects of insulin-like growth factor I and growth hormone.
    Scheven BA; Hamilton NJ
    Acta Endocrinol (Copenh); 1991 May; 124(5):602-7. PubMed ID: 2028719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factors and bone: the osteoporosis connection revisited.
    Rosen CJ; Donahue LR
    Proc Soc Exp Biol Med; 1998 Oct; 219(1):1-7. PubMed ID: 9751217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined treatment with GH and IGF-I: additive effect on cortical bone mass but not on linear bone growth in female rats.
    Sundström K; Cedervall T; Ohlsson C; Camacho-Hübner C; Sävendahl L
    Endocrinology; 2014 Dec; 155(12):4798-807. PubMed ID: 25243853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of thyroid hormone action on the insulin-like growth factor system: all thyroid hormone effects are not growth hormone mediated.
    Näntö-Salonen K; Muller HL; Hoffman AR; Vu TH; Rosenfeld RG
    Endocrinology; 1993 Feb; 132(2):781-8. PubMed ID: 7678799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone-dependent insulin-like growth factor binding protein is a major determinant of bone mineral density in healthy men.
    Johansson AG; Forslund A; Hambraeus L; Blum WF; Ljunghall S
    J Bone Miner Res; 1994 Jun; 9(6):915-21. PubMed ID: 7521562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTH ameliorates acidosis-induced adverse effects in skeletal growth centers: the PTH-IGF-I axis.
    Green J; Goldberg R; Maor G
    Kidney Int; 2003 Feb; 63(2):487-500. PubMed ID: 12631114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of growth hormone and insulin-like growth factor I in men with idiopathic osteoporosis.
    Johansson AG; Lindh E; Blum WF; Kollerup G; Sørensen OH; Ljunghall S
    J Clin Endocrinol Metab; 1996 Jan; 81(1):44-8. PubMed ID: 8550792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of recombinant human growth hormone and insulin-like growth factor-I, with or without 17 beta-estradiol, on bone and mineral homeostasis of aged ovariectomized rats.
    Verhaeghe J; van Bree R; Van Herck E; Thomas H; Skottner A; Dequeker J; Mosekilde L; Einhorn TA; Bouillon R
    J Bone Miner Res; 1996 Nov; 11(11):1723-35. PubMed ID: 8915780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.